WEDBUSH SECURITIES INC - NYMOX PHARMACEUTICAL CORP ownership

NYMOX PHARMACEUTICAL CORP's ticker is NYMX and the CUSIP is P73398102. A total of 46 filers reported holding NYMOX PHARMACEUTICAL CORP in Q3 2018. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
WEDBUSH SECURITIES INC ownership history of NYMOX PHARMACEUTICAL CORP
ValueSharesWeighting
Q3 2020$47,000
-58.0%
19,100
-39.6%
0.01%
-54.5%
Q2 2020$112,000
+41.8%
31,600
-6.8%
0.01%
+22.2%
Q1 2020$79,000
-15.1%
33,900
-20.2%
0.01%
+12.5%
Q4 2019$93,000
-19.1%
42,477
-32.3%
0.01%
-27.3%
Q3 2019$115,000
-34.3%
62,700
-48.2%
0.01%
-38.9%
Q2 2019$175,000
-21.9%
120,935
+6.3%
0.02%
-25.0%
Q1 2019$224,000
+17.9%
113,735
-21.6%
0.02%0.0%
Q4 2018$190,000
-50.5%
145,135
-7.0%
0.02%
-45.5%
Q3 2018$384,000
-48.0%
155,985
-29.0%
0.04%
-52.2%
Q2 2018$739,000
-29.6%
219,828
-11.3%
0.09%
-32.8%
Q1 2018$1,049,000
+14.6%
247,911
-10.6%
0.14%
+22.3%
Q4 2017$915,000
-7.8%
277,177
+6.7%
0.11%
-13.2%
Q3 2017$992,000
-4.0%
259,692
+10.7%
0.13%
-3.7%
Q2 2017$1,033,000
+58.4%
234,692
+30.6%
0.13%
+52.3%
Q1 2017$652,000
+40.5%
179,692
+3.5%
0.09%
+29.4%
Q4 2016$464,000
-21.4%
173,693
-4.0%
0.07%
-22.7%
Q3 2016$590,000
-16.9%
180,945
-14.6%
0.09%
-24.1%
Q2 2016$710,000
+36.8%
211,943
-0.3%
0.12%
+28.9%
Q1 2016$519,000
-25.6%
212,593
-0.1%
0.09%
-28.6%
Q4 2015$698,000212,7230.13%
Other shareholders
NYMOX PHARMACEUTICAL CORP shareholders Q3 2018
NameSharesValueWeighting ↓
MARATHON CAPITAL MANAGEMENT 55,000$179,0000.09%
WEDBUSH SECURITIES INC 180,945$590,0000.09%
Brown Advisory Securities, LLC 28,000$91,0000.03%
FNY Managed Accounts LLC 8,000$26,080,0000.02%
FT Options LLC 10,000$26,0000.02%
WEBSTER BANK, N. A. 40,000$130,0000.02%
GSA CAPITAL PARTNERS LLP 30,907$101,0000.01%
GOFEN & GLOSSBERG LLC /IL/ 25,000$82,0000.00%
NATIONAL PLANNING CORP 11,000$32,0000.00%
Virtu KCG Holdings LLC 24,705$81,0000.00%
View complete list of NYMOX PHARMACEUTICAL CORP shareholders